Patents by Inventor JUDD E. SHELLITO

JUDD E. SHELLITO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigens of and uses thereof
    Patent number: 10117913
    Abstract: A surface protein of the murine fungal pathogen Pneumocystis murina can be used to generate an immune response in a recipient animal or human that provides prophylactic protection and an anti-fungal activity in subjects already infected with a Pneumocystis species. Further, the disclosure provides novel polypeptides or peptides derived from the P. murina surface protein Surface Peptidase 1 (SPD-1) that are useful, alone or in combination with the SPD-1 polypeptide, in compositions and methods for the generation of an anti-Pneumocystis immune reaction by a recipient subject. The compositions and methods of the disclosure provide advantageous alternatives to available immunogenic determinants for the treatment or prevention of fungal pneumonia.
    Type: Grant
    Filed: May 4, 2015
    Date of Patent: November 6, 2018
    Assignees: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY, THE UNIVERSITY OF NEW ORLEANS
    Inventors: Judd E. Shellito, Alistair John Ramsay, David A. Welsh, Sanbao Ruan, Yang Cai
  • ANTIGENS OF PNEUMOCYSTIS MURINA AND USES THEREOF
    Publication number: 20170042988
    Abstract: A surface protein of the murine fungal pathogen Pneumocystis murina can be used to generate an immune response in a recipient animal or human that provides prophylactic protection and an anti-fungal activity in subjects already infected with a Pneumocystis species. Further, the disclosure provides novel polypeptides or peptides derived from the P. murina surface protein Surface Peptidase 1 (SPD-1) that are useful, alone or in combination with the SPD-1 polypeptide, in compositions and methods for the generation of an anti-Pneumocystis immune reaction by a recipient subject. The compositions and methods of the disclosure provide advantageous alternatives to available immunogenic determinants for the treatment or prevention of fungal pneumonia.
    Type: Application
    Filed: May 4, 2015
    Publication date: February 16, 2017
    Inventors: JUDD E. SHELLITO, ALISTAIR JOHN RAMSAY, DAVID A. WELSH, SANBAO RUAN, YANG CAI